Loading clinical trials...
Loading clinical trials...
A Pilot Double Blind Placebo Controlled Crossover Study to Explore Possible Benefits of AUT00063, An Oral Modulator of Voltage - Gated Potassium Channels , In Adults Post-lingual Unilateral Cochlear Implant Recipients
Conditions
Interventions
AUT00063
Placebo
Locations
4
United Kingdom
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Royal National Throat, Nose and Ear Hospital
London, United Kingdom
Manchester Royal Infirmary
Manchester, United Kingdom
Start Date
May 1, 2016
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
May 24, 2017
NCT05668338
NCT06058767
NCT07222202
NCT07218913
NCT07156825
NCT05805384
Lead Sponsor
Autifony Therapeutics Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions